Q6P988 (NOTUM_HUMAN) Homo sapiens (Human)

Palmitoleoyl-protein carboxylesterase NOTUM UniProtKBInterProSTRINGInteractive Modelling

496 aa; Sequence (Fasta)

Available Structures

140 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH O-PALMITOLEOYL SERINE - CRYSTAL FORM IX - 1.5A
4uzq
 Heteromer
O00755; 		87-451
2×NAG; 4×NA; 6×CL; 2×PAM;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM VIII - PHOSPHATE COMPLEX - 2.4A
4uza
homo-3-mer83-451
3×NAG; 3×PO4;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I APO - 2.2A
4wbh
homo-2-mer86-451
4×CL; 1×NAG; 1×SO4;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I HEPARIN FRAGMENT COMPLEX - 1.7A
4uyw
monomer85-451
1×SGN; 1×NAG;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I IODIDE COMPLEX - 2.3A
4uyu
monomer85-451
1×NAG; 5×IOD; 1×CL;
Assess
Structure of the Wnt deacylase Notum in complex with isoquinoline 45
6r8r
monomer86-451
1×NAG; 1×JV8; 8×SO4; 5×DMS; 10×EDO;
Assess
Notum Inhibitor ARUK3004048
8bt8
monomer86-451
1×NAG; 7×SO4; 2×DMS; 4×EDO; 1×RRI;
Assess
ARUK3000263 complex with Notum
6zvl
monomer86-451
1×NAG; 4×SO4; 2×DMS; 1×EDO; 1×QR2;
Assess
Notum Inhibitor ARUK3004556
8bti
monomer86-451
1×NAG; 5×SO4; 1×DMS; 8×EDO; 1×RFO;
Assess
Notum Inhibitor ARUK3004308
8bta
monomer86-451
1×NAG; 3×SO4; 4×DMS; 2×EDO; 1×RC6;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A
4uz1
monomer86-451
1×NAG; 4×SO4;
Assess
Notum Inhibitor ARUK3004558
8btc
monomer86-451
1×NAG; 3×SO4; 1×DMS; 4×EDO; 1×RIQ;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM V - SOS COMPLEX - 1.9A
4uz6
monomer86-451
1×GU4; 1×NAG; 1×CL;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I MYRISTOLEATE COMPLEX - 2.1A
4uzl
monomer86-451
1×MYZ;
Assess
Notum_Ghrelin complex
6zyf
monomer86-451
1×NAG; 1×K4Q;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM VII - SOS COMPLEX - 2.2A
4uz9
monomer86-451
1×GU4; 1×NAG; 1×CL;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM II - 2.8A
4uyz
monomer87-452
Assess
Notum complex with ARUK3003910
7b2y
monomer87-451
1×NAG; 7×SO4; 1×DMS; 1×SRQ; 4×EDO; 1×GOL;
Assess
Theophylline-Notum complex
6tuz
monomer87-451
5×SO4; 4×DMS; 20×EDO; 1×NAG; 1×TEP;
Assess
Notum complex with ARUK3003906
7b2v
monomer87-451
1×NAG; 6×SO4; 1×DMS; 1×SRH; 4×EDO; 1×GOL;
Assess
Notum complex with ARUK3003902
7b3g
monomer87-451
1×NAG; 7×SO4; 3×DMS; 2×EDO; 1×SSQ;
Assess
Notum complex with ARUK3003775
7b3p
monomer87-451
6×SO4; 2×DMS; 2×EDO; 1×SUQ;
Assess
Notum Inhibitor ARUK3004552
8bth
monomer87-451
1×NAG; 5×SO4; 2×DMS; 3×EDO; 1×RJ0;
Assess
Notum complex with ARUK3003778
7b50
monomer87-451
5×SO4; 3×DMS; 1×SXQ;
Assess
Notum complex with ARUK3003718
7b37
monomer87-451
1×NAG; 4×SO4; 3×DMS; 2×EDO; 1×SRK;
Assess
Notum complex with ARUK3003776
7b3i
monomer87-451
7×SO4; 3×DMS; 3×EDO; 1×STK;
Assess
Notum complex with ARUK3003934
7b45
monomer87-451
1×NAG; 7×SO4; 3×DMS; 1×EDO; 1×SWQ;
Assess
Notum S232A in complex with ARUK3003718
7b3f
monomer87-451
1×NAG; 4×SO4; 3×DMS; 2×EDO; 1×SRK;
Assess
Furano[2,3-d]prymidine amides as Notum inhibitors
6t2h
monomer87-451
2×DMS; 7×SO4; 13×EDO; 1×NAG; 1×M9N;
Assess
Notum Cotinine
7bnf
monomer87-451
7×SO4; 7×GOL; 1×NAG; 1×U5H;
Assess
ARUK3001043_Notum
7qvz
monomer87-451
1×NAG; 2×EDO; 1×SO4; 1×FNW; 2×DMS;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A BENZOTRIAZOLE FRAGMENT
6r8q
monomer87-451
1×NAG; 8×SO4; 5×EDO; 1×JV5;
Assess
Notum_ARUK3000438
7pjr
monomer87-451
1×NAG; 2×DMS; 1×7SQ; 4×SO4;
Assess
Notum Inhibitor ARUK3004470
8bte
monomer87-451
1×NAG; 6×SO4; 1×DMS; 3×EDO; 1×RIX;
Assess
Notum_Inhibitor ARUK3000223
7pkv
monomer87-451
6×SO4; 1×NAG; 1×DMS; 1×63Z;
Assess
Notum fragment_126 (2-(1,2-dihydroacenaphthylen-5-ylsulfanyl)acetic acid)
7bnc
monomer87-451
7×SO4; 1×GOL; 1×NAG; 1×U5B;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLE-3-CARBOXYLIC ACID FRAGMENT 454
6yuw
monomer87-451
2×SO4; 1×PQZ; 1×NAG;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLIDINE-3-CARBOXYLIC ACID FRAGMENT 587
6yv0
monomer87-451
1×SO4; 4×EDO; 1×PQT; 1×NAG;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLE-3-CARBOXYLIC ACID FRAGMENT 686
6yv4
monomer87-451
1×PQK; 1×NAG; 2×SO4; 5×EDO;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A
4uz5
monomer87-451
1×NAG; 1×CL;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM VI - 2.2A
4uz7
monomer87-451
1×CL;
Assess
Notum fragment_1 (2-(isoquinolin-1-ylsulfanyl)acetic acid)
7bn5
monomer87-451
3×SO4; 1×GOL; 1×NAG; 1×U4K;
Assess
Notum fragment_50 (3-(quinazolin-4-ylsulfanyl)propanoic acid)
7bnb
monomer88-451
6×SO4; 1×NAG; 3×DMS; 1×U58;
Assess
Notum-maybridge_18
7bls
monomer88-451
5×SO4; 1×NAG; 2×DMS; 1×GOL; 1×U2Q;
Assess
Notum_Maybridge_4
7blt
monomer88-451
5×SO4; 1×NAG; 1×U2T;
Assess
Notum Fragment_130 (4H-thieno[3,2-c]chromene-2-carboxylic acid)
7bo2
monomer88-451
6×SO4; 1×NAG; 7×EDO; 1×U62; 3×DMS;
Assess
1-phenylpyrroles and 1-enylpyrrolidines as inhibitors of Notum
6ysk
monomer88-451
1×NAG; 4×SO4; 1×DMS; 8×EDO; 1×PJK;
Assess
Notum_Maybridge_56
7blu
monomer88-451
5×SO4; 1×NAG; 2×DMS; 1×GOL; 1×U2W;
Assess
Notum ARUK3003710
7bnl
monomer88-451
1×NAG; 7×SO4; 3×DMS; 1×EDO; 1×U5T;
Assess
Notum-Fragment 110
7b8a
monomer88-451
3×SO4; 1×NAG; 1×AWP; 8×EDO;
Assess
Notum in complex with ARUK3002704
7arg
monomer88-451
1×NAG; 6×SO4; 1×DMS; 5×EDO; 1×RW8;
Assess
Notum complex with ARUK3003907
7b2z
monomer88-451
5×SO4; 4×DMS; 1×SQW;
Assess
Notum complex with ARUK3002697
7b4x
monomer88-451
7×SO4; 3×DMS; 4×EDO; 1×SWT;
Assess
Notum complex with ARUK3003909
7b3h
monomer88-451
6×SO4; 3×EDO; 1×SSW; 1×DMS;
Assess
Notum Fragment 923
7bdc
monomer88-451
3×SO4; 1×NAG; 4×DMS; 1×WNA;
Assess
Notum Fragment 297
7b9i
monomer88-451
5×SO4; 1×NAG; 2×DMS; 2×T3T;
Assess
Notum complex with ARUK3003748
7b3x
monomer88-451
6×SO4; 1×DMS; 1×SUT;
Assess
Structure of Notum in complex with a 1-(3-Chlorophenyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid i…
6yxi
monomer88-451
1×PZ8; 1×NAG; 1×DMS; 7×SO4; 2×EDO;
Assess
N-acetylserotonin-Notum complex
6tr6
monomer88-451
1×NAG; 4×SO4; 2×EDO; 4×DMS; 2×ASE;
Assess
Notum-Fragment065
7b84
monomer88-451
5×SO4; 1×NAG; 6×EDO; 3×JFS; 5×DMS;
Assess
Notum_Valsartan complex
7bm1
monomer88-451
6×SO4; 1×NAG; 6×EDO; 1×U35; 3×DMS;
Assess
Notum Fragment_130_methyEster (methyl 4H-thieno[3,2-c]chromene-2-carboxylate)
7bo5
monomer88-451
6×SO4; 1×NAG; 2×DMS; 1×GOL; 1×U65;
Assess
Furano[2,3-d]prymidine amides as Notum inhibitors
6t2k
monomer88-451
5×SO4; 1×NAG; 1×M9K; 4×EDO;
Assess
Notum Inhibitor ARUK3004903
8bt7
monomer88-451
1×NAG; 5×SO4; 1×DMS; 6×EDO; 1×RL6;
Assess
Notum Inhibitor ARUK3004877
8bt5
monomer88-451
1×NAG; 5×SO4; 2×DMS; 4×EDO; 1×REH;
Assess
Notum Fragment_274 [(4-fluorophenyl)amino]thiourea
7bo1
monomer88-451
6×SO4; 1×GOL; 1×EDO; 3×U5Z; 3×DMS;
Assess
Notum Fragment 927
7bdf
monomer88-451
3×SO4; 1×NAG; 1×DMS; 1×TEH;
Assess
Notum Rosmarinic acid complex
7bm3
monomer88-451
9×SO4; 1×NAG; 4×EDO; 3×ROA;
Assess
Notum-Fragment067
7b86
monomer88-451
3×SO4; 1×NAG; 1×AW7; 16×EDO;
Assess
Notum_ARUK3001185
7pk3
monomer88-451
5×SO4; 1×NAG; 1×7T0; 1×DMS;
Assess
Notum Fragment 872
7bd8
monomer88-451
4×SO4; 1×NAG; 3×DMS; 1×QL5;
Assess
Notum-Fragment 147
7b8c
monomer88-451
7×SO4; 1×NAG; 1×DMS; 1×EDO; 1×GRV;
Assess
Notum-Fragment 174
7b8l
monomer88-451
6×SO4; 1×NAG; 3×EDO; 1×AY4;
Assess
Notum Inhibitor ARUK3006561
8bsq
monomer88-451
5×SO4; 1×NAG; 1×DMS; 1×RDO;
Assess
Notum Inhibitor ARUK3006562
8bsr
monomer88-451
6×SO4; 1×NAG; 1×DMS; 1×RCU; 3×EDO;
Assess
Notum_Piperine complex
7blw
monomer88-451
5×SO4; 1×NAG; 2×DMS; 1×AYR;
Assess
Notum TDZD8 complex
7bmd
monomer88-451
11×SO4; 4×GOL; 1×NAG; 1×U3W; 1×DMS;
Assess
Notum fragment 723
6r8p
monomer88-451
1×NAG; 2×GOL; 12×SO4; 1×DMS; 1×JVB;
Assess
Notum Fragment 916
7bdb
monomer88-451
3×SO4; 1×NAG; 1×DMS; 1×NW7;
Assess
Notum Fragment 924
7bdd
monomer88-451
3×SO4; 1×NAG; 1×DMS; 1×TE8;
Assess
N-[2-(5-fluoro-1H-indol-3-yl)ethyl]acetamide-Notum complex
6tr7
monomer88-451
6×SO4; 12×EDO; 1×NAG; 2×HWH;
Assess
Notum-Bepridil complex
7bli
monomer88-451
5×SO4; 1×NAG; 1×BEP; 2×DMS;
Assess
Notum Fragment 900
7bda
monomer88-451
6×SO4; 1×NAG; 2×DMS; 1×O1J;
Assess
Notum-Fragment064
7b7y
monomer88-451
4×SO4; 1×NAG; 6×EDO; 2×JFP;
Assess
Notum-Fragment 193
7b8m
monomer88-451
4×SO4; 1×NAG; 1×EDO; 1×GQM;
Assess
Notum Riluzole
7bnj
monomer88-451
13×SO4; 1×NAG; 2×DMS; 1×657;
Assess
Notum Fragment 609
7b9u
monomer88-451
5×SO4; 1×NAG; 3×DMS; 1×O3D;
Assess
Notum-Fragment 199
7b8o
monomer88-451
7×SO4; 1×NAG; 4×EDO; 1×T1W;
Assess
Melatonin-Notum complex
6tr5
monomer88-451
2×ML1; 1×DMS; 1×NAG; 8×SO4;
Assess
Notum Fragment 714
7bcd
monomer88-451
4×SO4; 1×NAG; 1×DMS; 1×T9Z;
Assess
Notum-Fragment 210
7b8x
monomer88-451
2×SO4; 1×NAG; 2×DMS; 1×U3K;
Assess
Notum Fragment 810
7bd2
monomer88-451
5×SO4; 2×DMS; 1×NUM;
Assess
CFF-Notum complex
6tv4
monomer88-451
12×SO4; 1×NAG; 2×DMS; 1×CFF; 5×GOL;
Assess
Notum Fragment 282
7b98
monomer88-451
7×SO4; 1×NAG; 2×EDO; 1×EJW;
Assess
Notum Fragment 648
7bap
monomer88-451
4×SO4; 1×NAG; 2×S4V; 3×DMS;
Assess
Notum Fragment 955
7bdh
monomer88-451
3×SO4; 1×NAG; 1×DMS; 2×TEZ;
Assess
Notum fragment 286
6zuv
monomer88-451
1×NAG; 6×SO4; 3×EDO; 1×B1J;
Assess
Notum-Fragment 201
7b8u
monomer88-451
6×SO4; 1×NAG; 1×RUY;
Assess
Notum Fragment 646
7bac
monomer88-451
5×SO4; 1×NAG; 1×DMS; 2×LO5;
Assess
Notum Inhibitor ARUK3006560
8bsp
monomer88-451
5×SO4; 1×NAG; 1×DMS; 1×RD9;
Assess
Notum-Fragment 197
7b8n
monomer88-451
6×SO4; 1×NAG; 1×GOL; 4×EDO; 1×T2E;
Assess
Notum-Fragment 276
7b8y
monomer88-451
4×SO4; 1×NAG; 2×DMS; 1×T2H;
Assess
Notum-Fragment 159
7b8g
monomer88-451
6×SO4; 1×NAG; 1×MJW;
Assess
Notum Fragment 705
7bcc
monomer88-451
5×SO4; 1×NAG; 1×TB5;
Assess
Notum-Fragment074
7b87
monomer88-451
2×DMS; 7×EDO; 3×SO4; 1×NAG; 1×JFV;
Assess
Notum Fragment 886
7bd9
monomer88-451
3×SO4; 1×NAG; 1×DMS; 1×GW1;
Assess
Notum Inhibitor ARUK3005518
8bt0
monomer88-451
1×NAG; 4×SO4; 1×DMS; 6×EDO; 1×RGO;
Assess
Notum-Fragment049
7b7w
monomer88-451
2×SO4; 1×NAG; 3×EDO; 1×JGA;
Assess
Notum Fragment 934
7bdg
monomer88-451
5×SO4; 1×NAG; 1×DMS; 1×TEK;
Assess
Notum-Fragment 173
7b8k
monomer88-451
3×SO4; 1×NAG; 1×EDO; 1×AXV;
Assess
Notum-Fragment 151
7b8d
monomer88-451
5×SO4; 1×NAG; 1×DMS; 1×SFY;
Assess
Notum-Fragment 154
7b8f
monomer88-451
4×SO4; 1×NAG; 3×EDO; 1×RYM;
Assess
Notum Fragment 830
7bd5
monomer88-451
2×SO4; 1×NAG; 1×YI6;
Assess
Notum Fragment 772
7bch
monomer88-451
4×SO4; 1×NAG; 1×T9Q;
Assess
Notum Fragment 791
7bck
monomer88-451
2×SO4; 1×T9B;
Assess
Notum Inhibitor ARUK3005522
8bsz
monomer88-451
1×NAG; 4×SO4; 1×DMS; 6×EDO; 1×RGU;
Assess
Notum Fragment 863
7bd6
monomer88-451
3×SO4; 1×NAG; 3×DMS; 1×JH7;
Assess
Notum Inhibitor ARUK3004876
8bt2
monomer88-451
1×NAG; 4×SO4; 1×DMS; 6×EDO; 1×RG0;
Assess
Notum Nicotine
7bne
monomer88-451
2×GOL; 2×SO4; 1×NAG; 1×NCT;
Assess
Notum Fragment 690
7bc9
monomer88-451
6×SO4; 1×NAG; 1×DMS; 1×UR4;
Assess
Notum-Fragment 277
7b8z
monomer88-451
7×SO4; 1×NAG; 1×DMS; 1×A6Z;
Assess
Notum Fragment 658
7bc8
monomer88-451
6×SO4; 1×NAG; 2×EDO; 1×TAH;
Assess
Notum-Fragment 163
7b8j
monomer88-451
5×SO4; 1×NAG; 1×BP4;
Assess
Notum fragment_3 (4H,5H-naphtho[1,2-b]thiophene-2-carboxylic acid)
7bn8
monomer88-451
1×NAG; 4×SO4; 1×U4T;
Assess
Notum Fragment 828
7bd4
monomer88-451
4×SO4; 1×NAG; 1×JHJ;
Assess
Notum Fragment 283
7b99
monomer88-451
9×SO4; 1×NAG; 1×B1A; 1×DMS;
Assess
Notum PPOH complex
7bmb
monomer88-451
5×SO4; 1×NAG; 2×DMS; 1×GOL; 1×U3T;
Assess
Notum Fragment 792
7bcl
monomer88-451
2×SO4; 1×NAG; 1×DMS; 1×T9K;
Assess
Notum-Fragment077
7b89
monomer88-451
3×SO4; 1×NAG; 1×T1Z; 11×EDO;
Assess
Notum Fragment 722
7bcf
monomer88-451
5×SO4; 1×NAG; 1×T9W;
Assess
Notum fragment 5e
7bm7
monomer88-451
4×SO4; 1×NAG; 2×DMS; 1×U3Q;
Assess
Notum Fragment 823
7bd3
monomer88-451
5×SO4; 1×NAG; 1×TE5;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLE-3-CARBOXYLIC ACID FRAGMENT 471
6yuy
monomer88-451
16×SO4; 1×DMS; 1×PQH; 1×NAG;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLIDINE-3-CARBOXYLIC ACID FRAGMENT 598
6yv2
monomer88-451
1×NAG; 1×PUE; 3×SO4; 3×EDO;
Assess
Notum_Fragment41 (N-methyl-4,5-dihydronaphtho,2-bthiophene-2-carboxamide)
7bnd
monomer88-451
1×NAG; 6×SO4; 1×GOL; 1×U5E;
Assess
Notum-Fragment063
7b7x
monomer88-451
3×SO4; 1×NAG; 5×EDO; 1×WKA;
Assess
Notum Fragment 588
7b9n
monomer89-451
6×SO4; 1×NAG; 3×DMS; 2×N9J;
Assess
Notum Fragment 634
7ba1
monomer89-451
5×SO4; 1×NAG; 1×DMS; 1×S1V;
Assess
Notum Fragment 290
7b9d
monomer88-450
4×SO4; 1×NAG; 1×T3N;
Assess
Notum Fragment 784
7bci
monomer88-450
5×SO4; 1×NAG; 2×GVV;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4wbh.1.Ahomo-2-mer0.8686-451
100.00
Assess